Organoid

Organoid is a self-organizing three-dimensional microtissue grown in vitro from pluripotent stem cells or adult tissue-resident stem and progenitor cells that reproduces defining histological compartments, multilineage cell diversity, and physiological activities of an in vivo organ. Unlike two-dimensional monolayers plated on rigid polystyrene or homogeneous multicellular aggregates lacking tissue polarity, organoids rely on cell-intrinsic developmental programs and basement-membrane signaling to break spatial symmetry autonomously. Across intestinal crypts, optic cups, cortical vesicles, nephrons, hepatic buds, and endometrial glands, organoid platforms bridge reductionist cell lines and animal models in developmental biology, infectious disease research, oncology pharmacotyping, and preclinical toxicology.

Adult Stem-Cell-Derived Epithelial Organoids

Modern adult stem-cell organoid culture originated in 2009 when Toshiro Sato and Hans Clevers at the Hubrecht Institute isolated single leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5⁺) crypt base columnar stem cells from mouse small intestine and embedded them in laminin-rich basement-membrane extract (Matrigel) without mesenchymal stroma. Supplemented with R-spondin-1 (an LGR4/5 ligand blocking RNF43/ZNRF3-mediated Frizzled turnover to potentiate Wnt signaling), epidermal growth factor (EGF), Noggin (a bone morphogenetic protein antagonist), and—for colonic or human tissues—exogenous Wnt3A plus TGF-β and p38 MAPK inhibitors, single LGR5⁺ cells proliferated and budded continuously into polarized crypt–villus mini-guts. Crypt domains generated Paneth cells interspersed with LGR5⁺ stem cells, while central villus-like domains accumulated absorptive enterocytes, mucin-secreting goblet cells, and enteroendocrine cells shedding into an enclosed lumen. Tailoring this Wnt/R-spondin niche cocktail enabled long-term expansion of adult epithelial organoids from human colon, stomach, liver bile ducts, pancreas, prostate, mammary gland, endometrium, and bronchioalveolar lung.

Pluripotent Stem-Cell-Derived Multi-Layer Organoids

Whereas adult stem-cell organoids model homeostatic renewal in tissues possessing active adult stem compartments, organs with minimal postnatal turnover—such as the brain, retina, and kidney glomerulus—are generated from embryonic stem cells or induced pluripotent stem cells. Pioneered by Yoshiki Sasai via serum-free floating culture of embryoid body-like aggregates with quick reaggregation (SFEBq), stepwise morphogen exposure guided self-organization of stratified cortical neuroepithelium (2008), two-walled optic cups forming retinal organoids (2011), and anterior pituitary pouches (2011). In 2013, Madeline A. Lancaster and Jürgen A. Knoblich embedded human neuroectodermal embryoid bodies in Matrigel droplets agitated inside spinning bioreactors to produce multi-regional cerebral organoids, while Takanori Takebe co-cultured human endoderm with mesenchymal and endothelial progenitors to form vascularizable liver buds, and Minoru Takasato and Ryuji Morizane directed intermediate mesoderm into nephron kidney organoids containing podocyte glomeruli, proximal tubules, loops of Henle, and distal collecting ducts.

Differential Cell Adhesion and Intrinsic Symmetry Breaking

Initially uniform cell aggregates partition into ordered tissue layers without external spatial templates through three coupled biophysical mechanisms formalized by Sasai: cell sorting, spatially restricted lineage commitment, and cell-shape-driven tissue mechanics. Under Malcolm Steinberg's differential adhesion and cortical tension framework, cells expressing distinct classical cadherins (E-cadherin vs. N-cadherin or P-cadherin) and ephrin–Eph repulsive receptors minimize interfacial free energy by sorting into homotypic domains. Even within uniform LGR5⁺ intestinal cysts, transient cell-to-cell heterogeneity in nuclear YAP1 mechanotransduction at the eight-to-sixteen-cell stage induces focal DLL1 expression in a single cell; lateral Notch activation in neighbors suppresses secretory fate while converting the DLL1⁺ cell into a Wnt3-secreting Paneth cell, breaking spherical symmetry to nucleate the first crypt bud.

Reaction–Diffusion Gradients and Extracellular Matrix Mechanosensing

Once symmetry breaks, short-range activators coupled to faster-diffusing inhibitors establish Turing-type reaction–diffusion morphogen fields—such as crypt-base Wnt3 opposed by villus BMP2/BMP4, or Nodal opposed by Lefty in gastruloids—that space buds and axes across 80–250 μm wavelengths. Simultaneously, epithelial polarity and folding depend on reciprocal signaling with the extracellular matrix. Engagement of basal α₆β₁ and α₃β₁ integrins by laminin-111 and collagen IV orients the intracellular PAR3–PAR6–aPKC complex to position tight junctions (ZO-1) and podocalyxin-lined lumens apically. Because mouse sarcoma Matrigel exhibits batch-to-batch proteomic variability and xenogeneic origin, bioengineers cultivate clinical and quantitative organoids in chemically defined polyethylene glycol, alginate, or hyaluronic acid hydrogel scaffolds tuned to physiological elastic moduli (E ≈ 0.2–2.0 kPa) with protease-cleavable crosslinks and RGD or IKVAV adhesion peptides.

Cystic Fibrosis Swelling Assays and Oncology Pharmacotyping

Because adult epithelial organoids expand clonally from endoscopic biopsies or surgical resections while preserving donor germline and somatic genomes, living organoid biobanks enable functional precision medicine. In cystic fibrosis, Jeffrey M. Beekman, Johanna F. Dekkers, and Hans Clevers (2013) developed the forskolin-induced swelling (FIS) assay on patient rectal organoids: forskolin activates adenylyl cyclase to raise cyclic AMP and open wild-type apical CFTR Cl⁻/HCO₃⁻ channels, driving osmotic H₂O influx that swells healthy organoids within 60 minutes, whereas CFTR-mutant organoids remain collapsed unless rescued ex vivo by modulators (ivacaftor, tezacaftor, elexacaftor). For rare CFTR genotypes unsuited to large clinical trials, rectal organoid FIS responses predict patient sweat-chloride reduction and lung-function gains. In oncology, patient-derived tumor organoids (PDOs) from colorectal, pancreatic, gastroesophageal, breast, and ovarian carcinomas preserve parental driver mutations (KRAS, TP53, APC, SMAD4), predicting clinical chemotherapy and targeted-inhibitor responses with 80–90% negative predictive value and ~70–85% positive predictive value.

Microfluidic Perfusion and the FDA Modernization Act 2.0

To overcome the ~400–500 μm passive O₂ diffusion limit in static hydrogel domes, investigators engineer vascularized organoids containing perfusable endothelial networks or integrate organoid epithelia into microfluidic organ-on-a-chip devices exposing tissues to luminal shear stress, peristaltic strain, and commensal microbes. Addressing poor interspecies concordance of animal toxicology for human-specific biologics and idiosyncratic hepatotoxicity or cardiotoxicity, the United States enacted the FDA Modernization Act 2.0 in December 2022 (Public Law 117-328), amending Section 505(i) of the Federal Food, Drug, and Cosmetic Act to remove the mandatory animal-testing requirement prior to human clinical trials and qualify human organoids as non-animal preclinical efficacy and safety standards.

How does an organoid differ from a spheroid and an organ-on-a-chip?

A spheroid forms by forced cell clustering in low-attachment wells without stem-cell self-organization or basement-membrane polarity. An organoid arises from stem or progenitor cells that autonomously proliferate, differentiate into multiple organ-specific lineages, and self-organize into polarized tissue compartments. An organ-on-a-chip is a microengineered fluidic device whose pre-patterned channels apply controlled flow and mechanical stretch; hybrid organoid-on-a-chip platforms unite intrinsic morphogenesis with microfluidic perfusion.

Why do pluripotent-stem-cell organoids arrest at a fetal maturation state?

Pluripotent organoids initiate differentiation from an embryonic epiblast state in the absence of postnatal systemic cues—including pulsatile thyroid and glucocorticoid hormones, vascular blood flow, circadian nutrient cycles, peripheral innervation, and resident immune cells. Extended bioreactor perfusion, fatty-acid oxidative media, triiodothyronine supplementation, electrical pacing, and neuro-vascular co-culture advance adult-like functional maturity.

How do researchers access the enclosed apical lumen of epithelial organoids?

When embedded in basement-membrane hydrogels, basal integrins face outward so apical microvilli seal around an internal cavity. Investigators deliver microbes or drugs into this lumen either by glass-micropipette microinjection or by removing extracellular matrix proteins so the epithelium everts into apical-out organoids exposing microvilli directly to the medium.

1. Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., ... & Clevers, H. (2009). Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature, 459(7244), 262–265. https://doi.org/10.1038/nature07935
2. Eiraku, M., Takata, N., Ishibashi, H., Kawada, M., Sakakura, E., Okuda, S., ... & Sasai, Y. (2011). Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature, 472(7341), 51–56. https://doi.org/10.1038/nature09941
3. Dekkers, J. F., Wiegerinck, C. L., de Jonge, H. R., Bronsveld, I., Janssens, H. M., de Winter-de Groot, K. M., ... & Beekman, J. M. (2013). A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nature Medicine, 19(7), 939–945. https://doi.org/10.1038/nm.3201
4. Lancaster, M. A., & Knoblich, J. A. (2014). Organogenesis in a dish: Modeling development and disease using organoid technologies. Science, 345(6194), 1247125. https://doi.org/10.1126/science.1247125
5. Clevers, H. (2016). Modeling development and disease with organoids. Cell, 165(7), 1586–1597. https://doi.org/10.1016/j.cell.2016.05.082